MSKCC Update in Hematology and Medical Oncology 2025

Name: MSKCC Update in Hematology and Medical Oncology 2025
Availability: InStock

$106

Secure checkoutEncrypted, private payment

Delivery Via Fast Download linkDownloadable Files from Google Drive

Easy accessDownload and learn without streaming

Email supportQuick help with questions

Categories: All Products, Hematology, Memorial Sloan Kettering Cancer Center (MSKCC CME), Oncology

Description

MSKCC Update in Hematology and Medical Oncology 2025

Include: 47 videos 48 pdfs, size: 21.4 GB

Date & Location: Friday, March 7, 2025, 9:00 AM – Monday, March 10, 2025, 2:45 PM, Online

Specialties – Hematology, Infectious Diseases, Medical Oncology, Oncology and Hematology, Radiation Oncology, Surgical Oncology

Overview

The 13th Annual Board Review and Comprehensive Update in Hematology and Medical Oncology, condensed into an intensive three-and-a-half-day virtual program, provides a thorough and up-to-date review of the diagnosis, staging, and management of neoplastic diseases, encompassing both solid tumors and hematologic malignancies. Lectures and discussions focus on disease-specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology.

This course is a live virtual event designed for medical oncology professionals, including physicians, nurses, pharmacists, fellows, and residents. It aims to help participants effectively prepare for the American Board of Internal Medicine certification and recertification examinations in Hematology and Medical Oncology.

Specialties

Specialties – Hematology, Infectious Diseases, Medical Oncology, Oncology and Hematology, Radiation Oncology, Surgical Oncology

This 13th Annual Board Review and Comprehensive Update in Hematology and Medical Oncology offers an in-depth and current review of the diagnosis, staging,and management of neoplastic diseases,encompassing both solid tumors and hematologic malignancies. Expert-led lectures and discussions cover disease-specific topics across gastrointestinal, gynecologic, thoracic, ead and neck, genitourinary, soft tissue and skin, and central nervous system cancers, as well as hematologic malignancies. This program is designed to support participants in their preparation for the American Board of Internal Medicine (ABIM) certification and recertification examinations in Hematology and Medical Oncology and is now avaible on website

Objectives

At the conclusion of this course, attendees will be able to:

Define state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers.
Discuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice
Prepare for ABIM examinations in medical oncology and hematology.

Schedule

Friday, March 7, 2025

Relevant Financial Relationships

9:00AM – 9:10AM

Colon Cancer
9:15AM – 10:00AM
Leonard B Saltz, MD

Melanoma
10:00AM – 10:45AM
Michael Postow, MD

Kidney Cancer
10:45AM – 11:30AM
Robert Motzer, MD

Prostate Cancer
11:30AM – 12:15PM
Susan Slovin, MD, PhD

Mesothelioma
12:15PM – 1:00PM
Michael Offin, MD

Urothelial Cancer
1:15PM – 2:00PM
Gopakumar Iyer, MD

Testis Cancer
2:00PM – 2:45PM
Darren Feldman, MD

Uterine, Cervix, and Other Gynecologic Cancers
2:45PM – 3:30PM
Carol Aghajanian, MD

Ovarian Cancer
3:45PM – 4:30PM
Rachel Grisham, MD

Breast Cancer Surgery
4:30PM – 5:00PM
Anita Mamtani, MD

Breast Cancer Radiation Therapy
5:00PM – 5:30PM
Lior Braunstein, MD

Hereditary Cancer Genetics
5:30PM – 6:00PM
Zsofia Stadler, MD

Saturday, March 8, 2025

Small Cell Lung Cancer
7:00AM – 7:30AM
Alissa Cooper, MD

HER2-Positive Breast Cancer
7:30AM – 8:20AM
Joshua Drago, MD

Triple-Negative Breast Cancer
8:20AM – 9:10AM
Rachel Sanford, MD

Hormone Receptor-Positive Breast Cancer
9:10AM – 10:00AM
Devika Gajria, MD

Carcinoma of Unknown Primary
10:00AM – 10:30AM
Anna Mary Varghese, MD

Hepatocellular Cancer and Cholangiocarcinoma
10:45AM – 11:30AM
Ghassan K Abou-Alfa, MD, JD, MBA

Pancreatic and Neuroendocrine Cancers
11:30AM – 12:15PM
Eileen M O’Reilly, MD

Non-Small Cell Lung Cancer
1:00PM – 2:00PM
Gregory Riely, MD

Head and Neck, Thyroid, and Non-Melanoma Skin Cancers
2:00PM – 3:00PM
Lara Dunn, MD

Anal and Rectal Cancers
3:00PM – 3:45PM
Andrea Cercek, MD

Esophageal and Gastric Cancers
3:45PM – 4:30PM
David Ilson, MD, PhD

Central Nervous System Tumors
4:30PM – 5:00PM
Thomas Kaley, MD

Sarcoma
5:00PM – 5:45PM
Robert G Maki, MD, PhD

Infectious Disease
5:45PM – 6:15PM
Susan Seo, MD

Sunday, March 9, 2025

Pharmacology I_II PT. 1
7:00AM – 9:00AM
Mrinal Gounder, MD

Pharmacology I_II PT. 2
7:00AM – 7:10AM
Mrinal Gounder, MD

Acute Myeloid Leukemia
9:10AM – 9:50AM
Eytan Stein, MD

Low-Grade Non-Hodgkin Lymphoma
9:50AM – 10:30AM
Andrew D Zelenetz, MD, PhD

Chronic Lymphocytic Leukemia _Small Lymphocytic Lymphoma
10:30AM – 11:10AM
Meghan C Thompson, MD

Diffuse Large B-Cell Lymphoma _Mantle Cell Lymphoma _Burkitt Lymphoma
11:10AM – 12:10PM
Paul A Hamlin, MD

Hodgkin Lymphoma _ T Cell
12:40PM – 1:40PM
Alison Moskowitz, MD

Auto _Allo
1:40PM – 2:20PM
Gunjan Shah , MD, MS

CAR T Cells
2:20PM – 2:50PM
Craig Sauter, MD

Acute Lymphocytic Leukemia
2:50PM – 3:20PM
Mark B Geyer , MD

Myeloproliferative Neoplasms
3:40PM – 4:05PM
Raajit Rampal, MD, PhD

Myelodysplastic
4:05PM – 4:30PM
Aaron D Goldberg, MD

Chronic Myelogenous Leukemia
4:30PM – 5:00PM
Michael Mauro, MD

Myeloma _Amyloid
5:00PM – 6:00PM
Malin Hultcrantz, MD, PhD

Monday, March 10, 2025

Approach to the Bleeding Patient
8:05AM – 8:50AM
Avi Leader, MD

Thrombotic Disorders
8:50AM – 9:50AM
Jeffrey Zwicker, MD

Antithrombotic and Antiplatelet Therapy
9:50AM – 10:30AM
Simon Mantha, MD, MPH

Thrombocytopenia and ITP
10:30AM – 11:00AM
Cy R Wilkins, MD

Sickle Cell Disease, Thalassemia
11:00AM – 12:00PM
Susanna Curtis, MD, PhD

Hemolytic Anemia
12:30PM – 1:05PM
Gerald Soff, MD

Clinical Indications for Use of Blood Products and Associated Risks
1:05PM – 2:00PM
P. Dayand D Borge Jr., MD, PhD

Transfusion Reactions
2:00PM – 2:45PM
Grace E Linder, MD

Topics:

Acute Lymphocytic Leukemia.mp4
Acute Lymphocytic Leukemia.pdf
Acute Myeloid Leukemia.mp4
Acute Myeloid Leukemia.pdf
Anal and Rectal Cancers.mp4
Anal and Rectal Cancers.pdf
Antithrombotic and Antiplatelet Therapy.mp4
Antithrombotic and Antiplatelet Therapy.pdf
Approach to the Bleeding Patient.mp4
Approach to the Bleeding Patient.pdf
Auto _Allo.mp4
Auto _Allo.pdf
Breast Cancer Radiation Therapy.mp4
Breast Cancer Radiation Therapy.pdf
Breast Cancer Surgery.mp4
Breast Cancer Surgery.pdf
CAR T Cells.mp4
CAR T Cells.pdf
Carcinoma of Unknown Primary.mp4
Carcinoma of Unknown Primary.pdf
Central Nervous System Tumors.mp4
Central Nervous System Tumors.pdf
Chronic Lymphocytic Leukemia _Small Lymphocytic Lymphoma.mp4
Chronic Lymphocytic Leukemia _Small Lymphocytic Lymphoma.pdf
Chronic Myelogenous Leukemia.mp4
Chronic Myelogenous Leukemia.pdf
Clinical Indications for Use of Blood Products and Associated Risks.mp4
Clinical Indications for Use of Blood Products and Associated Risks.pdf
Colon Cancer.mp4
Colon Cancer.pdf
Diffuse Large B-Cell Lymphoma _Mantle Cell Lymphoma _Burkitt Lymphoma.mp4
Diffuse Large B-Cell Lymphoma _Mantle Cell Lymphoma _Burkitt Lymphoma.pdf
Esophageal and Gastric Cancers.mp4
Esophageal and Gastric Cancers.pdf
Head and Neck, Thyroid, and Non-Melanoma Skin Cancers.mp4
Head and Neck, Thyroid, and Non-Melanoma Skin Cancers.pdf
Hemolytic Anemia.mp4
Hemolytic Anemia.pdf
HemOnc2025_Brochure.pdf
Hepatocellular Cancer and Cholangiocarcinoma.mp4
Hepatocellular Cancer and Cholangiocarcinoma.pdf
HER2-Positive Breast Cancer.mp4
HER2-Positive Breast Cancer.pdf
Hereditary Cancer Genetics.mp4
Hereditary Cancer Genetics.pdf
Hodgkin Lymphoma _ T Cell.mp4
Hodgkin Lymphoma _ T Cell.pdf
Hormone Receptor-Positive Breast Cancer.mp4
Hormone Receptor-Positive Breast Cancer.pdf
Infectious Disease.mp4
Infectious Disease.pdf
Kidney Cancer.mp4
Kidney Cancer.pdf
Low-Grade Non-Hodgkin Lymphoma.mp4
Low-Grade Non-Hodgkin Lymphoma.pdf
Melanoma.mp4
Melanoma.pdf
Mesothelioma.mp4
Mesothelioma.pdf
Myelodysplastic.mp4
Myelodysplastic.pdf
Myeloma _Amyloid.mp4
Myeloma _Amyloid.pdf
Myeloproliferative Neoplasms.mp4
Myeloproliferative Neoplasms.pdf
Non-Small Cell Lung Cancer.mp4
Non-Small Cell Lung Cancer.pdf
Ovarian Cancer.mp4
Ovarian Cancer.pdf
Pancreatic and Neuroendocrine Cancers.mp4
Pancreatic and Neuroendocrine Cancers.pdf
Pharmacology I_II.mp4
Pharmacology I_II.pdf
Prostate Cancer.mp4
Prostate Cancer.pdf
Sarcoma.mp4
Sarcoma.pdf
Sickle Cell Disease, Thalassemia.mp4
Sickle Cell Disease, Thalassemia.pdf
Small Cell Lung Cancer.mp4
Small Cell Lung Cancer.pdf
Testis Cancer.mp4
Testis Cancer.pdf
Thrombocytopenia and ITP.mp4
Thrombocytopenia and ITP.pdf
Thrombotic Disorders.mp4
Thrombotic Disorders.pdf
Transfusion Reactions.mp4
Transfusion Reactions.pdf
Triple-Negative Breast Cancer.mp4
Triple-Negative Breast Cancer.pdf
Urothelial Cancer.mp4
Urothelial Cancer.pdf
Uterine, Cervix, and Other Gynecologic Cancers.mp4
Uterine, Cervix, and Other Gynecologic Cancers.pdf